| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC | VP Chief Financial Officer | Common Stock | 26K | $47.1K | $1.81 | Mar 23, 2024 | Direct |
| CUMBERLAND PHARMACEUTICALS INC | VP Chief Financial Officer | Options (right to buy) | 12.5K | $21.4K | $1.71 | Mar 25, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 23, 2024 | 2 | $8.6K | 4 | Mar 26, 2024 | VP Chief Financial Officer |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Nov 27, 2023 | 1 | -$588 | 4 | Dec 6, 2023 | Chief Financial Officer |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 24, 2023 | 1 | $0 | 4 | Mar 27, 2023 | Chief Financial Officer |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 16, 2022 | 2 | $51.8K | 4 | Apr 29, 2022 | Chief Financial Officer |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Nov 23, 2021 | 1 | $8.93K | 4 | Dec 3, 2021 | Chief Financial Officer |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | May 17, 2021 | 0 | $0 | 3 | Jul 9, 2021 | Chief Financial Officer |